Anixa Biosciences CEO Kumar Amit purchased 3,000 shares at $2.75 each, an open-market transaction recorded on September 10, 2026. The purchase left Amit with 665,000 shares, while the transaction represented about 0.5% of his resulting holding, giving investors a precise view of the executive’s post-purchase position.

Key Highlights

  • Kumar Amit held 665,000 Anixa Biosciences shares after the transaction.
  • The purchase represented about 0.5% of his resulting shareholding.
  • The transaction was reported under SEC transaction code P.

Anixa Biosciences Inc (NASDAQ: ANIX) Chief Executive Officer Kumar Amit purchased 3,000 shares at $2.75 per share. The transaction was recorded on September 10, 2026, and classified under code P.

CEO’s Post-Purchase Holding Reaches 665,000 Shares

His ownership stood at 665,000 shares after the purchase. The transaction represented about 0.5% of that resulting holding. The percentage is tied specifically to Amit’s post-transaction share position. The purchase price was stated on a per-share basis. The reported transaction involved Anixa Biosciences shares, with Amit named as the purchaser. The resulting holding figure reflects the shares owned after the transaction was completed.